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Accepted 14 August 2013AbstractObjective: This study was aimed at detection of recurrent transmission of the 17q12 microdeletion in a fetus with congenital anomalies of the
kidney and urinary tract.
Materials and Methods: A 35-year-old woman was referred to the hospital at 20 weeks’ gestation because of hydronephrosis in the fetus. The
mother was normal and healthy. Her second child was a girl who had bilateral dysplastic kidneys that required hemodialysis, and died at the age
of 5 years. During this pregnancy, the woman underwent amniocentesis at 18 weeks’ gestation because of advanced maternal age. Cytogenetic
analysis revealed a karyotype of 46,XY. Prenatal ultrasound showed left hydronephrosis with a tortuous ureter, right hydronephrosis, and
increased echogenicity of the kidneys. Fetal magnetic resonance imaging showed right dilated renal calyces, left hydronephrosis, hydroureter,
and multicystic kidney. The pregnancy was subsequently terminated. Array comparative genomic hybridization (aCGH) and fluorescence in situ
hybridization were applied for genetic analysis using umbilical cord, maternal blood, and cultured amniocytes.
Results: aCGH analysis on umbilical cord detected a 1.75-Mb deletion at 17q12 including haploinsufficiency of LHX1 and HNF1B. aCGH
analysis on maternal blood detected a 1.54-Mb deletion at 17q12 including haploinsufficiency of LHX1 and HNF1B. Metaphase fluorescence in
situ hybridization analysis on cultured amniocytes and maternal blood lymphocytes using 17q12-specific bacterial artificial chromosome probe
showed 17q12 microdeletion in the fetus and the mother.* Corresponding author. Department of Obstetrics and Gynecology, Mackay Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan.
E-mail address: cpc_mmh@yahoo.com (C.-P. Chen).
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Congenital anomalies of the kidney and urinary tract
(CAKUT) occur in three to seven in 1000 births [1e5]. Uni-
lateral dysplastic kidney occurs in one in 1000 and bilateral
dysplastic kidneys occur in one in 5000 of the general popu-
lation [6]. About 10% of the patients with CAKUT have a
family history of CAKUT indicating a genetic pathogenesis of
these disorders [4e6].
Chromosome 17q12 deletion syndrome (OMIM 614527) is
a contiguous gene syndrome caused by 17q12 deletion with
clinical phenotypic features including renal cysts and diabetes
consistent with maturity-onset diabetes of the young type 5
(MODY5; OMIM 137920) [7e9], Mu¨llerian aplasia/dysgen-
esis [10,11], autism spectrum disorder and schizophrenia
[12,13], and speech delay, learning difficulty, transient
neonatal hypercalcemia, and neonatal cholestasis [14].
Here, we present our experience of detection of recurrent
transmission of 17q12 microdeletion by array comparative
genomic hybridization (aCGH) in a fetus with prenatal ultra-
sound diagnosis of hydronephrosis, hydroureter, multicystic
kidney, and variable clinical spectrum in the family.
Materials and methodsClinical descriptionA 35-year-old, gravida 3, para 1, woman was referred to the
hospital at 20 weeks’ gestation because of hydronephrosis in
the fetus. The mother was normal and healthy. She did not
have mental disorder, behavior disorder, diabetes mellitus, orFig. 1. Prenatal ultrasound at 21 weeks’ gestation shows bilateral hydro-
nephrosis, tortuous left ureter, and increased echogenicity of the kidneys.genitourinary abnormalities. Her husband was 36 years old.
The couple had a healthy 8-year-old daughter. Their second
child was a girl who had bilateral dysplastic kidneys that
required hemodialysis, and died at the age of 5 years. During
this pregnancy, the woman underwent amniocentesis at 18
weeks’ gestation because of advanced maternal age. Cytoge-
netic analysis revealed a karyotype of 46,XY. Prenatal ultra-
sound showed left hydronephrosis with a tortuous ureter, right
hydronephrosis, and increased echogenicity of the kidneys
(Fig. 1). The amniotic fluid amount was normal. Fetal mag-
netic resonance imaging at 21 weeks’ gestation showed right
dilated renal calyces, left hydronephrosis, hydroureter, and
multicystic kidney (Fig. 2). The pregnancy was terminated at
23 weeks’ gestation, and a 737-g male fetus was delivered
with no facial dysmorphism and abnormalities of male
external genitalia.aCGHWhole-genome aCGH analysis on the DNA extracted from
umbilical cord was performed using NimbleGen ISCA Plus
Cytogenetic Array (Roche NimbleGen, Madison, WI, USA).
The NimbleGen ISCA Plus Cytogenetic Array has 630,000
probes and a median resolution of 15e20 kb across the entire
genome according to the manufacturer’s instructions. Parental
blood and the healthy elder daughter’s blood were also
collected, and the samples were subjected to aCGH analysis
using the same array kit. The DNA from the cells was
extracted first. It was done by following the manufacturer’s
protocol of the QIAamp DNA Mini kit (Qiagen, Valencia, CA,
USA). Then, 0.5 mg of the extracted DNA was labeled with
Cy5 dye and compared with an equivalent amount of normal
female genomic DNA (G1521; Promega) labeled with Cy3
dye to perform the aCGH experiment. The experiment was
performed according to the procedures recommended in the
Roche NimbleGen ISCA plus Cytogenetic Array user guide.
The data were finally presented using Nexus 6.1 (Bio-
Discovery, Hawthorne, CA, USA).Fluorescence in situ hybridizationMetaphase fluorescence in situ hybridization (FISH) anal-
ysis was performed on cultured amniocytes derived from the
stored amniotic fluid and maternal blood using a 17q12-
specific bacterial artificial chromosome (BAC) probe RP11-
143E18 (dye: Texas red) (35,985,121e36,129,469) and a
control 17q25.3-specific BAC probe RP11-388C12 (dye:
Fig. 2. Prenatal magnetic resonance imaging at 21 weeks’ gestation showed: (A) dilation of bilateral renal pelves and calyces (arrows), and marked dilation of left
ureter (B ¼ urinary bladder; S ¼ stomach; U ¼ ureter); (B) marked dilation of bilateral renal pelves (arrows) with more severe condition on the left side; and
(CeE) small renal cysts (arrows) in the left kidney without connection with the dilated renal pelvis.
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the standard FISH protocol [15].
Results
Whole-genome aCGH analysis on the DNA extracted from
umbilical cord detected a 1.75-Mb deletion at 17q12, or arr
[hg19] 17q12 (34,653,178e36,402,867)  1 (Fig. 3). The
deleted 17q12 region contained 29 genes involving 15 OMIM
genes including LHX1 and HNF1B. Whole-genome aCGH
analysis on the DNA extracted from maternal blood detected a
1.54-Mb deletion at 17q12, or arr [hg19] 17q12
(34,814,526e36,355,604)  1 (Fig. 4). The deleted 17q12
region contained 26 genes involving 13 OMIM genes
including LHX1 and HNF1B. Whole-genome aCGH analysis
on the DNA extracted from paternal blood and the healthyelder daughter’s blood showed no 17q12 microdeletion and no
other genomic imbalance. Metaphase FISH analysis on
cultured amniocytes and maternal blood lymphocytes using
17q12-specific BAC probe showed presence of only one 17q12
signal, indicating 17q12 microdeletion in the fetus and the
mother (Fig. 5).
Discussion
The present case is believed to be the first report of
detection of recurrent transmission of 17q12 microdeletion in
association with prenatally diagnosed hydronephrosis, hydro-
ureter, and bilateral multicystic kidneys in a fetus born to an
asymptomatic mother carrying a 17q12 microdeletion. In a
study of 62 pregnancies with fetal bilateral hyperechogenic
kidneys, Decramer et al [16] found that HNF1B gene
Fig. 3. Array comparative genomic hybridization analysis on the DNA extracted from umbilical cord shows a 1.75-Mb deletion at 17q12, or arr [hg19] 17q12
(34,653,178e36,402,867)  1. (A) Chromosomal view and (B) zoom in view.
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the 18 fetuses with HNF1B gene anomalies, 15 probands had a
complete heterozygous deletion of the HNF1B gene. Hendrix
et al [17] reported prenatal diagnosis of a 1.52-Mb 17q12
microdeletion encompassing HNF1B and LHX1 with nuchal
edema, bilateral echogenic kidneys, and a left-sided dia-
phragmatic hernia. Mefford et al [8] reported a 1.8-Mb 17q12
microdeletion encompassing HNF1B with bilateral multicystic
renal dysplasia, bilateral ureteropelvic junction stenosis,
atretic right ureter, and hypoplastic bladder. The present case
provides evidence that fetuses with a 17q12 microdeletion
encompassing HNF1B and LHX1 may prenatally present
hydronephrosis and hydroureter in the second trimester, in
addition to bilateral hyperechogenic kidneys [16,17] and
multicystic dysplastic kidneys [8].
The present fetus had a 1.75-Mb 17q12 microdeletion
encompassing HNF1B and LHX1, and phenotypic abnormal-
ities in the kidney and ureter. HNF1B (OMIM 189907) or
transcription factor-2 is a transcription factor that belongs to
the homeodomain-containing suprafamily of transcription
factors [18]. Heterozygous mutations in HNF1B are associated
with renal cysts and diabetes syndrome or MODY5, which is
an autosomal dominant disorder comprising diabetesoccurring earlier than age 25 years, and variable renal and
genital tract anomalies [19e31]. Mutations in HNF1B are
common in women with both uterine and renal abnormalities
[32]. 17q12 microdeletion involving HNF1B is associated with
MODY5 [8,9,28], MayereRokitanskyeKu¨stereHauser
(MRKH) syndrome and Mu¨llerian aplasia/dysgenesis [10,11],
and autism spectrum disorder and schizophrenia [12,13].
Thomas et al [33] reported identification of pathogenic
HNF1B or PAX2 mutations in 14% of Caucasian patients in a
North American cohort of children with renal hypoplasia.
HNF1B and PAX2 play key roles in early mouse urogenital
tract development [34]. Paces-Fessy et al [34] found that
HNF1B acts as a modifier of the PAX2 haploinsufficient
phenotype in a mouse model, and suggested that HNF1B and
PAX2 cooperate in a common pathway governing both kidney
morphogenesis and ureter differentiation. HNF1B deficiency is
associated with ciliary anomalies in cholangiocytes [35].
Roelandt et al [35] detected 17q12 microdeletion in two pa-
tients and HNF1B mutation in one patient with ciliary defects
in cholangiocytes.
LHX1 (OMIM 601999), also known as LIM1, belongs to
the LIM/homeobox gene family and is essential for head-
organizer function, renal, central nervous system and female
Fig. 4. Array comparative genomic hybridization analysis on the DNA extracted from maternal blood shows a 1.54-Mb deletion at 17q12, or arr [hg19] 17q12
(34,814,526-36,355,604)  1. (A) Chromosomal view and (B) zoom in view.
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found that female Lhx1-null mutant mice had ovaries but
lacked derivatives of the Mu¨llerian duct including uterus,
cervix and the upper vagina. Mutations of LHX1 are associated
with MRKH syndrome [43,44]. In a study of 56 patients with
MRKH syndrome, Ledig et al [43] detected 17q12 micro-
deletion encompassing LHX1 and HNF1B in two patients and
a missense mutation in LHX1 in one patient. Ledig et al [44]
additionally detected a frameshift mutation of LHX1 in a pa-
tient with MRKH syndrome and suggested that heterozygous
mutations of LHX1 might be one cause of MRKH syndrome.
However, Xia et al [45] performed LHX1 mutation screening
in 96 patients with Mu¨llerian duct abnormalities but found no
significant mutation in LHX1.
The present case provides evidence for variable clinical
spectrum associated with 17q12 microdeletion in the family.
In the present case, the carrier mother was asymptomatic, the
affected sibling had neonatal bilateral dysplastic kidneys, and
the affected fetus had congenital hydronephrosis, hydro-
ureter, and multicystic kidneys. A wide range of phenotypes
with considerable variability in expressivity can be observed
in the patients with 17q12 microdeletions [8,13,46]. In-
dividuals with nearly identical 17q12 deletions can have
variable phenotypic spectrum ranging from prenatallydetected renal disease, renal disease detected in childhood,
MODY5 diagnosed before age 40 years, to a mild phenotype
[8]. Mefford et al [8] suggested that early-onset renal disease
is more likely to occur in fetuses with a large genomic
deletion of 17q12 than those patients with a mutation in
HNF1B. Although the carrier mother in this case was
asymptomatic at the age of 35 years, she is at risk of diabetes,
renal disease and cognitive disorder in the future and should
undertake regular metabolic, renal, and mental examinations.
The considerable variability in the phenotypic expressivity
and the wide spectrum of the disease in the affected in-
dividuals with 17q12 microdeletion imply the necessity for
genetic counseling of familial transmission in the family
members under the circumstance of perinatally detected
17q12 microdeletion in the fetus.
aCGH has the advantages of detection of microdeletions or
microduplications in the fetuses with apparently normal kar-
yotype and prenatally detected structural abnormalities as well
as familial transmission of the genomic imbalance [47e50].
We suggest that prenatal diagnosis of recurrent renal and
urinary tract abnormalities in the fetuses should include a
differential diagnosis of familial 17q12 microdeletion.
In summary, we present molecular cytogenetic character-
ization of recurrent 17q12 microdeletion in a family with
Fig. 5. Metaphase fluorescence in situ hybridization analysis on (A) cultured
amniocytes and (B) maternal blood lymphocytes using a 17q12-specific bac-
terial artificial chromosome probe RP11-143E18 (dye: Texas red)
(35,985,121e36,129,469) and a control 17q25.3-specific bacterial artificial
chromosome probe RP11-388C12 (dye: FITC, green)
(80,606,711e80,718,184) [hg 19] shows presence of one red signal and one
green signal in a normal chromosome 17, and presence of only one green
signal in the aberrant chromosome 17, indicating 17q12 microdeletion.
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phenotype correlation in this case.
Acknowledgments
This work was supported by research grants NSC-99-2628-
B-195-001-MY3 and NSC-101-2314-B-195-011-MY3 from
the National Science Council and MMH-E-102-04 from
Mackay Memorial Hospital, Taipei, Taiwan.
References
[1] Livera LN, Brookfield DS, Egginton JA, Hawnaur JM. Antenatal ultra-
sonography to detect fetal renal abnormalities: A prospective screening
programme. BMJ 1989;298:1421e3.
[2] Pope 4th JC, Brock 3rd JW, Adams MC, Stephens FD, Ichikawa I. How
they begin and how they end: classic and new theories for thedevelopment and deterioration of congenital anomalies of the kidney and
urinary tract. CAKUT. J Am Soc Nephrol 1999;10:2018e28.
[3] Woolf AS. A molecular and genetic view of human renal and urinary
tract malformations. Kidney Int 2000;58:500e12.
[4] Nakayama M, Nozu K, Goto Y, Kamei K, Ito S, Sato H, et al. HNF1B
alterations associated with congenital anomalies of the kidney and uri-
nary tract. Pediatr Nephrol 2010;25:1073e9.
[5] Sanna-Cherchi S, Kiryluk K, Burgess KE, Bodria M, Sampson MG,
Hadley D, et al. Copy-number disorders are a common cause of
congenital kidney malformations. Am J Hum Genet 2012;91:987e97.
[6] Winyard P, Chitty LS. Dysplastic kidneys. Semin Fetal Neonatal Med
2008;13:142e51.
[7] Bellanne´-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M,
Douillard C, et al. Large genomic rearrangements in the hepatocyte
nuclear factor-1-b (TCF2) gene are the most frequent cause of maturity-
onset diabetes of the young type 5. Diabetes 2005;54:3126e32.
[8] Mefford HC, Clauin S, Sharp AJ, Moller RS, Ullmann R, Kapur R, et al.
Recurrent reciprocal genomic rearrangements of 17q12 are associated
with renal disease, diabetes, and epilepsy. Am J Hum Genet
2007;81:1057e69.
[9] Nagamani SCS, Erez A, Shen J, Li C, Roeder E, Cox S, Karaviti L, et al.
Clinical spectrum associated with recurrent genomic rearrangements in
chromosome 17q12. Eur J Hum Genet 2010;18:278e84.
[10] Cheroki C, Krepischi-Santos ACV, Szuhai K, Brenner V, Kim CAE,
Otto PA, et al. Genomic imbalances associated with mullerian aplasia. J
Med Genet 2008;45:228e32.
[11] Bernardini L, Gimelli S, Gervasini C, Carella M, Baban A, Frontino G,
et al. Recurrent microdeletion at 17q12 as a cause of Mayer-Rokitansky-
Kuster-Hauser (MRKH) syndrome: two case reports. Orphanet J Rare
Dis 2009;4:25.
[12] Loirat C, Bellanne´-Chantelot C, Husson I, Descheˆnes G, Guigonis V,
Chabane N. Autism in three patients with cystic or hyperechogenic
kidneys and chromosome 17q12 deletion. Nephrol Dial Transplant
2010;25:3430e3.
[13] Moreno-De-Luca D, SGENE Consortium, Mulle JG, Simons Simplex
Collection Genetics Consortium, Kaminsky EB, Sanders SJ, et al.
Deletion 17q12 is a recurrent copy number variant that confers high risk
of autism and schizophrenia. Am J Hum Genet 2010;87:618e30.
[14] Dixit A, Patel C, Harrison R, Jarvis J, Hulton S, Smith N, et al. 17q12
microdeletion syndrome: three patients illustrating the phenotypic
spectrum. Am J Med Genet 2012;158A:2317e21.
[15] Dyer K, Meyne J. Amniotic fluid II: in situ culture and harvesting:
coverslip processing method. In: Barch MJ, editor. The ACT cytogenetic
laboratory manual. 2nd ed. New York: Roven Press; 1991. p. 172e5.
[16] Decramer S, Parant O, Beaufils S, Clauin S, Guillou C, Kessler S, et al.
Anomalies of the TCF2 gene are the main cause of fetal bilateral
hyperechogenic kidneys. J Am Soc Nephrol 2007;18:923e33.
[17] Hendrix NW, Clemens M, Canavan TP, Surti U, Rajkovic A. Prenatally
diagnosed 17q12 microdeletion syndrome with a novel association with
congenital diaphragmatic hernia. Fetal Diagn Ther 2012;31:129e33.
[18] Bach I, Mattei M-G, Cereghini S, Yaniv M. Two members of an HNF1
homeoprotein family are expressed in human liver. Nuc Acids Res
1991;19:3553e9.
[19] Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN,
et al. Mutation in hepatocyte nuclear factor-1b gene (TCF2) associated
with MODY. Nat Genet 1997;17:384e5.
[20] Lindner TH, Njølstad PR, Horikawa Y, Bostad L, Bell GI, Søvik O. A
novel syndrome of diabetes mellitus, renal dysfunction and genital mal-
formation associated with a partial deletion of the pseudo-POU domain of
hepatocyte nuclear factor-1b. Hum Mol Genet 1999;8:2001e8.
[21] Bingham C, Ellard S, Allen L, Bulman M, Shepherd M, Frayling T, et al.
Abnormal nephron development associated with a frameshift mutation in
the transcription factor hepatocyte nuclear factor-1b. Kidney Int
2000;57:898e907.
[22] Bingham C, Bulman MP, Ellard S, Allen LIS, Lipkin GW, van’t
Hoff WG, et al. Mutations in the hepatocyte nuclear factor-1b gene are
associated with familial hypoplastic glomerulocystic kidney disease. Am
J Hum Genet 2001;68:219e24.
557C.-P. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 52 (2013) 551e557[23] Bingham C, Ellard S, van’t Hoff WG, Simmonds A, Marinaki AM,
Badman MK, et al. Atypical familial juvenile hyperuricemic nephropathy
associated with a hepatocyte nuclear factor-1b gene mutation. Kidney Int
2003;63:1645e51.
[24] Wild W, Pogge von Strandmann E, Nastos A, Senkel S, Lingott-Frieg A,
Bulman M, et al. The mutated human gene encoding hepatocyte nuclear
factor 1b inhibits kidney formation in developing Xenopus embryos. Proc
Nat Acad Sci USA 2000;97:4695e700.
[25] Iwasaki N, Okabe I, Momoi MY, Ohashi H, Ogata M, Iwamoto Y. Splice
site mutation in the hepatocyte nuclear factor-1b gene, IVS2ntþ1G-A,
associated with maturity-onset diabetes of the young, renal dysplasia
and bicornuate uterus. Diabetologia 2001;44:387e91.
[26] Kolatsi-Joannou M, Bingham C, Ellard S, Bulman MP, Allen LIS,
Hattersley AT, et al. Hepatocyte nuclear factor-1b: a new kindred with
renal cysts and diabetes and gene expression in normal human devel-
opment. J Am Soc Nephrol 2001;12:2175e80.
[27] Furuta H, Furuta M, Sanke T, Ekawa K, Hanabusa T, Nishi M, et al.
Nonsense and missense mutations in the human hepatocyte nuclear
factor-1b gene (TCF2) and their relation to type 2 diabetes in Japanese. J
Clin Endocr Metab 2002;87:3859e63.
[28] Bellanne´-Chantelot C, Chauveau D, Gautier J-F, Dubois-Laforgue D,
Clauin S, Beaufils S, et al. Clinical spectrum associated with hepatocyte
nuclear factor-1b mutations. Ann Intern Med 2004;140:510e7.
[29] Yorifuji T, Kurokawa K, Mamada M, Imai T, Kawai M, Nishi Y, et al.
Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys:
phenotypically discordant recurrence of a mutation in the hepatocyte
nuclear factor-1b gene due to germline mosaicism. J Clin Endocr Metab
2004;89:2905e8.
[30] Rebouissou S, Vasiliu V, Thomas C, Bellanne´-Chantelot C, Bui H,
Chre´tien Y, et al. Germline hepatocyte nuclear factor 1a and 1b muta-
tions in renal cell carcinomas. Hum Mol Genet 2005;14:603e14.
[31] Carette C, Vaury C, Barthe´le´my A, Clauin S, Gru¨nfeld J-P, Timsit J, et al.
Exonic duplication of the hepatocyte nuclear factor-1b gene (transcrip-
tion factor 2, hepatic) as a cause of maturity onset diabetes of the young
type 5. J Clin Endocr Metab 2007;92:2844e7.
[32] Oram RA, Edghill EL, Blackman J, Taylor MJO, Kay T, Flanagan SE,
et al. Mutations in the hepatocyte nuclear factor-1b (HNF1B) gene are
common with combined uterine and renal malformations but are not
found with isolated uterine malformations. Am J Obstet Gynecol
2010;203:364.e1e5.
[33] Thomas R, Sanna-Cherchi S, Warady BA, Furth SL, Kaskel FJ,
Gharavi AG. HNF1B and PAX2 mutations are a common cause of renal
hypodysplasia in the CKiD cohort. Pediatr Nephrol 2011;26:897e903.
[34] Paces-Fessy M, Fabre M, Lesaulnier C, Cereghini S. Hnf1b and Pax2
cooperate to control different pathways in kidney and ureter morpho-
genesis. Hum Mol Genet 2012;21:3143e55.
[35] Roelandt P, Antoniou A, Libbrecht L, Van Steenbergen W, Laleman W,
Verslype C, et al. HNF1B deficiency causes ciliary defects in human
cholangiocytes. Hepatology 2012;56:1178e81.[36] Shawlot W, Behringer RR. Requirement for Lim1 in head-organizer
function. Nature 1995;374:425e30.
[37] Bozzi F, Bertuzzi S, Strina D, Giannetto C, Vezzoni P, Villa A. The exon-
intron-structure of human LHX1 gene. Biochem Biophys Res Commun
1996;229:494e7.
[38] Kobayashi A, Shawlot W, Kania A, Behringer RR. Requirement of Lim1
for female reproductive tract development. Development
2004;131:539e49.
[39] Kobayashi A, Kwan K-M, Carroll TJ, McMahon AP, Mendelsohn CL,
Behringer RR. Distinct and sequential tissue-specific activities of the
LIM-class homeobox gene Lim1 for tubular morphogenesis during kid-
ney development. Development 2005;132:2809e23.
[40] Tam PPL, Khoo P-L, Wong N, Tsang TE, Behringer RR. Regionalization
of cell fates and cell movement in the endoderm of the mouse gastrula
and the impact of loss of Lhx1 (Lim1) function. Dev Biol
2004;274:171e87.
[41] Pedersen A, Skjong C, Shawlot W. Lim1 is required for nephric duct
extension and ureteric bud morphogenesis. Dev Biol 2005;288:571e81.
[42] Cirio MC, Hui Z, Haldin CE, Cosentino CC, Stuckenholz C, Chen X,
et al. Lhx1 is required for specification of the renal progenitor cell field.
PLoS One 2011;6:e18858.
[43] Ledig S, Schippert C, Strick R, Beckmann MW, Oppelt PG, Wieacker P.
Recurrent aberrations identified by array-CGH in patients with Mayer-
Rokitansky-Ku¨ster-Hauser syndrome. Fertil Steril 2011;95:1589e94.
[44] Ledig S, Brucker S, Barresi G, Schomburg J, Rall K, Wieacker P. Frame
shift mutation of LHX1 is associated with Mayer-Rokitansky-Ku¨ster-
Hauser (MRKH) syndrome. Hum Reprod 2012;27:2872e5.
[45] Xia M, Zhao H, Qin Y, Mu Y, Wang J, Bian Y, et al. LHX1 mutation
screening in 96 patients with mu¨llerian duct abnormalities. Fertil Steril
2012;97:682e5.
[46] George AM, Love DR, Hayes I, Tsang B. Recurrent transmission of a
17q12 microdeletion and a variable clinical spectrum. Mol Syndromol
2012;2:72e5.
[47] Chen C-P, Su Y-N, Chang T-Y, Chern S-R, Tsai F-J, Hwang JK, et al.
22q11.2 microdeletion in a fetus with double-outlet right ventricle,
pulmonary stenosis and a ventricular septal defect by array comparative
genomic hybridization. Taiwan J Obstet Gynecol 2009;48:437e40.
[48] Chen C-P, Su Y-N, Hsu C-Y, Liu Y-P, Chern S-R, Chen L-F, et al. Pre-
natal diagnosis of a de novo 17p13.1 microduplication in a fetus with
ventriculomegaly and lissencephaly. Taiwan J Obstet Gynecol
2011;50:554e7.
[49] Chen C-P, Lin C-J, Chen C-Y, Chern S-R, Wu P-S, Su J-W, et al.
Maternal transmission of interstitial microdeletion of 5q13.2 detected
during prenatal diagnosis of coarctation of the aorta. Taiwan J Obstet
Gynecol 2013;52:303e5.
[50] Chen C-P, Huang J-P, Chen Y-Y, Chern S-R, Wu P-S, Su J-W, et al.
Chromosome 22q11.2 deletion syndrome: prenatal diagnosis and array
comparative genomic hybridization characterization using uncultured
amniocytes. Gene 2013;527:405e9.
